About us
Our business concept is to offer effective help against some of our most common diseases where viruses or bacteria play a decisive role. In that way we contribute to improved health and increased well-being, which in turn can bring positive effects in terms of health economics.

Enzymatica is established in Lund, Sweden.

Listing on Nasdaq First North
The last day of trading on AktieTorget was Friday, June 12 and the first day of trading on Nasdaq First North was Monday June 15, 2015. In connection with the listing the Board of Enzymatica has drawn up a company description that has now been published in Swedish.

External IR pages

Please visit Enzymaticas external Investor Relations pages: